Rare-disease genome interpretation, from VCF to a reviewed report
Upload a genome VCF, its structural-variant calls and the patient's HPO phenotypes. Seven interpretation tools run on a private server and are combined into one de-duplicated, ACMG-aligned report with secondary, haemoglobin and pharmacogenomic findings.
How it works
Alignment and variant calling stay in your own pipeline. NextVariant starts from the finished calls.
Upload
Small-variant VCF, optional SV VCF and HPO terms, through the browser or straight to the bucket from your local server.
Analyse
Exomiser runs first; the other tools you tick run afterwards in the same queue. The job page shows each tool's progress.
Review
One blended report lists each variant once, with the tools that support it, ready for review and sign-off.
Tools
Each tool looks at the case from a different angle. Agreement between them is shown in the report, not hidden behind one score.
Exomiser 15.1
Ranks variants by pathogenicity, frequency, inheritance and phenotype match, with ACMG classes and ClinVar.
LIRICAL 2.4
Ranks diseases by post-test probability from the same phenotypes and genotype.
SvAnna 1.2
Prioritises deletions, duplications, inversions and breakends against the phenotype.
AnnotSV 3.5
Annotates every SV with genes, known pathogenic regions and an ACMG/ClinGen class.
Phen2Gene 1.1
Ranks genes from the HPO terms alone, as an independent check on the gene list.
GADO 1.0
Predicts gene–phenotype links from expression data, including genes not yet linked to disease.
PharmCAT 3.4
Calls star alleles and phenotypes such as DPYD, CYP2C19 and TPMT, with CPIC and DPWG guidance.
All-P/LP pass
A phenotype-free run that lists every pathogenic or likely pathogenic variant carried.
The blended report
All tool outputs merged by variant, so each finding appears once, in the section where it belongs.
- Findings related to the indicationPathogenic and likely pathogenic variants in genes that match the phenotype, supported by at least two tools. VUS listed separately.
- Structural variantsSvAnna and AnnotSV results for genes that the small-variant tools also rank.
- Secondary findings · ACMG SF v3.3The 84 actionable genes, applying each gene's reporting rule (for example biallelic only for HFE and MUTYH).
- Haemoglobin variantsHBB and HBA1/HBA2 findings such as sickle cell trait, β- and α-thalassaemia, reported apart from the main result.
- PharmacogenomicsActionable drug–gene results, for example DPYD reduced function and fluoropyrimidines.
- Evidence across toolsWhich tools support each gene, so agreement and disagreement are visible.
1 likely pathogenic finding related to the indication (KCNQ2).
| Gene | Variant | Class |
|---|---|---|
| KCNQ2 | c.881C>THet · 4 tools | Likely pathogenic |
| SCN8A | c.2671G>AHet · 2 tools | VUS |
| DPYD | *1/c.2846A>TIntermediate metabolizer | Actionable |
Every report is an automated draft until a reviewer signs it off.
Data and access
Inputs
- PacBio HiFi: DeepVariant small variants, pbsv or Sawfish SVs
- Illumina WGS: DeepVariant, DRAGEN or GATK; Manta or DRAGEN SVs
- GRCh38 VCF or VCF.gz, plus HPO term IDs
- Bulk upload to the bucket for the bioinformatics team
Security
- Sign-in through Cloudflare Access, invited users only
- Files encrypted at rest in a private bucket in India (Mumbai)
- Upload credentials can write, never read or delete
- The server sleeps when idle and has no open ports
IGV review
Upload the BAM, confirm each reported variant in IGV on the server and add the snapshots to the report. BAMs are deleted after seven days.